<?xml version="1.0"?>
         <rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"
                xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"><channel>
        <ttl>60</ttl>
        <title>A Top 30 Stream of SANDBOX CREATIVE INC. Press Releases (in OGG format) via PRWeb</title>
        <link>http://www.prwebpodcast.com</link>
        <description>A Top 30 Stream of SANDBOX CREATIVE INC. Press Releases (in OGG format) via PRWeb</description>
        <managingEditor>podEditor@emediawire.com (PRWeb)</managingEditor>
        <webMaster>podMaster@emediawire.com</webMaster>
        <pubDate>Sun, 06 Jul 2008 14:14:00 -0700</pubDate>
        <category>SANDBOX CREATIVE INC.</category>
        <image>
         <url>http://www.prweb.com/prwebrss.gif</url>
          <width>130</width>
          <height>49</height>
          <title>PRWeb Podcasts</title>
          <link>http://prwebpodcast.com</link>
        </image>
        <copyright>Copyright PRWeb International, Inc.</copyright>
        <language>en-us</language>
        <docs>http://blogs.law.harvard.edu/tech/rss</docs>

        <itunes:subtitle>A Top 30 Stream of SANDBOX CREATIVE INC. Press Releases (in OGG format) via PRWeb</itunes:subtitle>
        <itunes:summary>A Top 30 Stream of SANDBOX CREATIVE INC. Press Releases (in OGG format) via PRWeb</itunes:summary>
        <itunes:owner>
          <itunes:email>podEditor@emediawire.com</itunes:email>
          <itunes:name>PR Web</itunes:name>
        </itunes:owner>
        <itunes:author>PRWeb</itunes:author>
        <itunes:category text="SANDBOX CREATIVE INC." />
        <itunes:explicit>no</itunes:explicit>
        <itunes:image href="http://www.prwebpodcast.com/prwebpodcast.jpg" />
<item>
                        <title>Blocked Legislation Ensures There is No Relief in Sight from Rising Drug Prices, Says DoctorSolve</title>
                        <link>http://www.prweb.com/releases/2007/5/prweb527905.htm</link>
                        <comments>http://www.prweb.com/releases/2007/5/prweb527905.htm</comments>
                        <description>Big Pharma succeeds once again in blocking drug importation and preventing negotiation of lower drug prices. [PRWeb May 29, 2007]</description>
                        <guid>http://www.prweb.com/releases/2007/5/prweb527905.htm</guid>
                        <pubDate>Fri, 25 May 2007 15:53:30 -0700</pubDate>
                        <author>podcrew@extrahoop.com</author>
                        <enclosure url="http://prwebpodcast.com/pod/527905/Blocked_Legislation_Ensures_There_is_No_Relief_in_Sight_from_Rising_Drug_Prices_Says_DoctorSolve.ogg"
                                length="4781086" type="application/ogg" />
                        <content:encoded><![CDATA[Vancouver, B.C. (PRWEB) May 29, 2007 -- Recently, thanks to the financial clout of Big Pharma, American consumers were dealt two major blows to their pocket books. 

In April, Republican Senate leaders blocked a bill that would allow Medicare to negotiate for lower prices for the drugs required by seniors under the Medicare Part D program. In May, adding insult to injury, Americans were betrayed again when a Republican amendment upheld the law blocking the importation of prescription drugs from other countries.

&quot;Americans are forced to pay the highest prices for medications in the world,&quot; says Dr. Paul Zickler of DoctorSolve Healthcare Services (<a href="http://www.doctorsolve.com" onclick="linkClick( this.href );"  target="_blank">www.doctorsolve.com</a>). &quot;Yet their politicians continually sabotage any efforts to assuage this cruel fact.&quot;

Why? Because there is more money in fleecing Americans than looking after their best interests. In 2006 alone, the drug industry spent $172 million on lobbying efforts. That&#039;s the kind of money that can make a break a political party&#039;s chances for re-election. 

Meanwhile, the plan that was intended to bring pharmaceutical prices down is doing quite the opposite. According to a report, released by the consumer health organization, Families USA, the median Part D drug price increase was 9.2 percent - almost four times the latest inflation rate of 2.4 percent, and almost three times the increase in this year&#039;s cost-of-living adjustment in Social Security (3.3 percent). 

&quot;The report shows that the cost of drugs most commonly used by seniors skyrocketed last year,&quot; says Zickler. &quot;For example, a year&#039;s supply of Lipitor, a cholesterol-lowering drug, went up 9.2 percent. Fosamax, used to treat osteoporosis, rose by 10.7 percent. The elderly are forced to pay unfair prices, while Big Pharma soaks up the profits.&quot;

&quot;American seniors are being forced to seek out affordable alternatives to get their meds because they cannot afford the inflated prices of US drugs,&quot; says Zickler. &quot;They come to us because they can save 30 - 70 percent, and they know we go to great lengths to protect their safety through our Safety Service Guarantee.

&quot;Unlike American politicians and the drug companies, we are DoctorSolve Healthcare Services put the interest of American seniors first.&quot;

DoctorSolve, a Canadian Internet-based pharmacy intermediary (license #BC Q37), offers lower-cost, long-term prescriptions. A professionally registered pharmacist fills all prescriptions. A certified member of the Canadian International Pharmacy Association, DoctorSolve is ranked as one of the best online pharmacies by PharmacyChecker.com. DoctorSolve has filled more than 550,000 U.S. prescriptions.

For more information, call 1-866-732-0305 or visit <a href="http://www.doctorsolve.com" onclick="linkClick( this.href );"  target="_blank">http://www.doctorsolve.com</a>

###]]></content:encoded>
                        <itunes:author>Terry Johnson</itunes:author>
                        <itunes:subtitle>Blocked Legislation Ensures There is No Relief in Sight from Rising Drug Prices, Says DoctorSolve</itunes:subtitle>
                        <itunes:summary><![CDATA[Vancouver, B.C. (PRWEB) May 29, 2007 -- Recently, thanks to the financial clout of Big Pharma, American consumers were dealt two major blows to their pocket books. 

In April, Republican Senate leaders blocked a bill that would allow Medicare to negotiate for lower prices for the drugs required by seniors under the Medicare Part D program. In May, adding insult to injury, Americans were betrayed again when a Republican amendment upheld the law blocking the importation of prescription drugs from other countries.

&quot;Americans are forced to pay the highest prices for medications in the world,&quot; says Dr. Paul Zickler of DoctorSolve Healthcare Services (<a href="http://www.doctorsolve.com" onclick="linkClick( this.href );"  target="_blank">www.doctorsolve.com</a>). &quot;Yet their politicians continually sabotage any efforts to assuage this cruel fact.&quot;

Why? Because there is more money in fleecing Americans than looking after their best interests. In 2006 alone, the drug industry spent $172 million on lobbying efforts. That&#039;s the kind of money that can make a break a political party&#039;s chances for re-election. 

Meanwhile, the plan that was intended to bring pharmaceutical prices down is doing quite the opposite. According to a report, released by the consumer health organization, Families USA, the median Part D drug price increase was 9.2 percent - almost four times the latest inflation rate of 2.4 percent, and almost three times the increase in this year&#039;s cost-of-living adjustment in Social Security (3.3 percent). 

&quot;The report shows that the cost of drugs most commonly used by seniors skyrocketed last year,&quot; says Zickler. &quot;For example, a year&#039;s supply of Lipitor, a cholesterol-lowering drug, went up 9.2 percent. Fosamax, used to treat osteoporosis, rose by 10.7 percent. The elderly are forced to pay unfair prices, while Big Pharma soaks up the profits.&quot;

&quot;American seniors are being forced to seek out affordable alternatives to get their meds because they cannot afford the inflated prices of US drugs,&quot; says Zickler. &quot;They come to us because they can save 30 - 70 percent, and they know we go to great lengths to protect their safety through our Safety Service Guarantee.

&quot;Unlike American politicians and the drug companies, we are DoctorSolve Healthcare Services put the interest of American seniors first.&quot;

DoctorSolve, a Canadian Internet-based pharmacy intermediary (license #BC Q37), offers lower-cost, long-term prescriptions. A professionally registered pharmacist fills all prescriptions. A certified member of the Canadian International Pharmacy Association, DoctorSolve is ranked as one of the best online pharmacies by PharmacyChecker.com. DoctorSolve has filled more than 550,000 U.S. prescriptions.

For more information, call 1-866-732-0305 or visit <a href="http://www.doctorsolve.com" onclick="linkClick( this.href );"  target="_blank">http://www.doctorsolve.com</a>

###]]></itunes:summary>

                        <itunes:category text="Business" /><itunes:category text="Health" /><itunes:category text="Health">
        <itunes:category text=" Fitness &amp; Nutrition" />
          </itunes:category><itunes:category text="Society &amp; Culture" />

                        <itunes:duration>00:15:00</itunes:duration>
                        <itunes:explicit>no</itunes:explicit>
                        <itunes:keywords></itunes:keywords>
                        </item>
<item>
                        <title>Revised Cholesterol Guidelines Suggest Millions of Low-Risk Patients Should Be on High-Risk Statins, Says DoctorSolve</title>
                        <link>http://www.prweb.com/releases/2007/4/prweb511983.htm</link>
                        <comments>http://www.prweb.com/releases/2007/4/prweb511983.htm</comments>
                        <description>Medical professionals question the motivation behind putting otherwise healthy patients on prescription drugs. [PRWeb Apr 3, 2007]</description>
                        <guid>http://www.prweb.com/releases/2007/4/prweb511983.htm</guid>
                        <pubDate>Wed, 21 Mar 2007 16:11:36 -0700</pubDate>
                        <author>podcrew@extrahoop.com</author>
                        <enclosure url="http://prwebpodcast.com/pod/511983/Revised_Cholesterol_Guidelines_Suggest_Millions_of_Low_Risk_Patients_Should_Be_on_High_Risk_Statins_Says_DoctorSolve.ogg"
                                length="5242607" type="application/ogg" />
                        <content:encoded><![CDATA[Vancouver, B.C (PRWeb) April 3, 2007 -- Recently, the guidelines for acceptable cholesterol levels were lowered causing widespread concern in the medical community. 

Experts quoted in the British Medical Journal stated that the new guidelines suggest that millions of low-risk patients should be put on high-dose statins. Researchers say they are not ready to unleash high-dose statins on the public because there is too little research on outcomes.

&quot;Statins are cholesterol-lowering wonder drugs that make sense for those who have already had heart disease,&quot; states Dr. Paul Zickler of DoctorSolve (<a href="http://www.doctorsolve.com" onclick="linkClick( this.href );"  target="_blank">www.doctorsolve.com</a>) online pharmacy services. &quot;But the concern with lower cholesterol level guidelines is that they significantly widen the group of people who are candidates for statins. Many patients with slightly elevated cholesterol levels may be otherwise healthy. For these people, improving diet, increasing exercise and stopping smoking can have the same effect as taking statins. And it&#039;s safer and less expensive.&quot; 

Statins have been around since 1987, and there is no doubt that they can produce health benefits for many people. But the long-term effects of statins have been very poorly studied. &quot;Prescribing a drug to a healthy person needlessly puts them at risk for a drug&#039;s side effects,&quot; says Zickler. In the case of statins, there are two very important side effects, although they are extremely rare: a muscle-wasting condition and liver damage. 

This isn&#039;t the first time that cholesterol level guidelines have been lowered. Selling Sickness, written by Ray Moynihan and Alan Cassels, states, &quot;according to the official US National Institutes of Health&#039;s cholesterol guidelines from the 1990s, thirteen million Americans might have warranted treatment with statins. In 2001, a new panel of experts rewrote those guidelines, and effectively raised that number to 36 million.&quot; 

In 2004, another new panel of experts updated those guidelines again, bringing the number to 40 million Americans eligible for statins. In both of the latter cases, members of the panels also served as paid speakers, consultants or researchers to the world&#039;s major drug companies. So, who are the lower cholesterol guidelines really benefiting? 

For patients who are in otherwise good health, Dr. Zickler advises that they &quot;ask for other suggestions on how to lower your cholesterol first through diet and exercise. You can also look at a tried and true product called Niacin (vitamin B3), available at your drugstore. Niacin can raise the levels of good cholesterol by as much as 30 percent. One of the side effects of Niacin is flushing, so look for long-acting or flush-free formulations.&quot; 

If there are definite indications for the use of cholesterol-lowering medications, there are several available by prescription such as Lipitor, Zocor, Pravachol and Crestor, and generic statins at considerable savings through <a href="http://www.doctorsolve.com" onclick="linkClick( this.href );"  target="_blank">www.doctorsolve.com</a>.

DoctorSolve, a Canadian Internet-based pharmacy intermediary (license #BC Q37) offers lower cost, long-term prescriptions. A professionally registered pharmacist fills all prescriptions. A certified member of the Canadian International Pharmacy Association, DoctorSolve is ranked one of the best online pharmacies by PharmacyChecker.com. DoctorSolve has filled more than 200,000 U.S prescriptions. 

For more information, call 1-866-732-0305 or visit <a href="http://www.doctorsolve.com" onclick="linkClick( this.href );"  target="_blank">http://www.doctorsolve.com</a>.

###]]></content:encoded>
                        <itunes:author>Dianne Bidewell</itunes:author>
                        <itunes:subtitle>Revised Cholesterol Guidelines Suggest Millions of Low-Risk Patients Should Be on High-Risk Statins, Says DoctorSolve</itunes:subtitle>
                        <itunes:summary><![CDATA[Vancouver, B.C (PRWeb) April 3, 2007 -- Recently, the guidelines for acceptable cholesterol levels were lowered causing widespread concern in the medical community. 

Experts quoted in the British Medical Journal stated that the new guidelines suggest that millions of low-risk patients should be put on high-dose statins. Researchers say they are not ready to unleash high-dose statins on the public because there is too little research on outcomes.

&quot;Statins are cholesterol-lowering wonder drugs that make sense for those who have already had heart disease,&quot; states Dr. Paul Zickler of DoctorSolve (<a href="http://www.doctorsolve.com" onclick="linkClick( this.href );"  target="_blank">www.doctorsolve.com</a>) online pharmacy services. &quot;But the concern with lower cholesterol level guidelines is that they significantly widen the group of people who are candidates for statins. Many patients with slightly elevated cholesterol levels may be otherwise healthy. For these people, improving diet, increasing exercise and stopping smoking can have the same effect as taking statins. And it&#039;s safer and less expensive.&quot; 

Statins have been around since 1987, and there is no doubt that they can produce health benefits for many people. But the long-term effects of statins have been very poorly studied. &quot;Prescribing a drug to a healthy person needlessly puts them at risk for a drug&#039;s side effects,&quot; says Zickler. In the case of statins, there are two very important side effects, although they are extremely rare: a muscle-wasting condition and liver damage. 

This isn&#039;t the first time that cholesterol level guidelines have been lowered. Selling Sickness, written by Ray Moynihan and Alan Cassels, states, &quot;according to the official US National Institutes of Health&#039;s cholesterol guidelines from the 1990s, thirteen million Americans might have warranted treatment with statins. In 2001, a new panel of experts rewrote those guidelines, and effectively raised that number to 36 million.&quot; 

In 2004, another new panel of experts updated those guidelines again, bringing the number to 40 million Americans eligible for statins. In both of the latter cases, members of the panels also served as paid speakers, consultants or researchers to the world&#039;s major drug companies. So, who are the lower cholesterol guidelines really benefiting? 

For patients who are in otherwise good health, Dr. Zickler advises that they &quot;ask for other suggestions on how to lower your cholesterol first through diet and exercise. You can also look at a tried and true product called Niacin (vitamin B3), available at your drugstore. Niacin can raise the levels of good cholesterol by as much as 30 percent. One of the side effects of Niacin is flushing, so look for long-acting or flush-free formulations.&quot; 

If there are definite indications for the use of cholesterol-lowering medications, there are several available by prescription such as Lipitor, Zocor, Pravachol and Crestor, and generic statins at considerable savings through <a href="http://www.doctorsolve.com" onclick="linkClick( this.href );"  target="_blank">www.doctorsolve.com</a>.

DoctorSolve, a Canadian Internet-based pharmacy intermediary (license #BC Q37) offers lower cost, long-term prescriptions. A professionally registered pharmacist fills all prescriptions. A certified member of the Canadian International Pharmacy Association, DoctorSolve is ranked one of the best online pharmacies by PharmacyChecker.com. DoctorSolve has filled more than 200,000 U.S prescriptions. 

For more information, call 1-866-732-0305 or visit <a href="http://www.doctorsolve.com" onclick="linkClick( this.href );"  target="_blank">http://www.doctorsolve.com</a>.

###]]></itunes:summary>

                        <itunes:category text="Business" /><itunes:category text="Health" /><itunes:category text="Society &amp; Culture" />

                        <itunes:duration>00:15:00</itunes:duration>
                        <itunes:explicit>no</itunes:explicit>
                        <itunes:keywords></itunes:keywords>
                        </item>
</channel>
</rss>